Show simple item record

dc.contributor.authorLuies, Laneke
dc.contributor.authorMienie, Japie
dc.contributor.authorMotshwane, Christinah
dc.contributor.authorLoots, Du Toit
dc.contributor.authorRonacher, Katharina
dc.date.accessioned2017-10-10T12:12:34Z
dc.date.available2017-10-10T12:12:34Z
dc.date.issued2017
dc.identifier.citationLuies, L. et al. 2017. Urinary metabolite markers characterizing tuberculosis treatment failure. Metabolomics, 13(10): Article no 124. [https://doi.org/10.1007/s11306-017-1261-4]en_US
dc.identifier.issn1573-3882
dc.identifier.issn1573-3890 (Online)
dc.identifier.urihttp://hdl.handle.net/10394/25764
dc.identifier.urihttps://doi.org/10.1007/s11306-017-1261-4
dc.identifier.urihttps://link.springer.com/article/10.1007/s11306-017-1261-4
dc.description.abstractBackground Considering that approximately 15% of the nine million new tuberculosis (TB) cases reported per annum are not treated successfully, new, distinctive and specific biomarkers are needed to better characterize the biological basis of a poor treatment outcome. Methods Urine samples from 41 active pulmonary TB patients were collected at baseline (time of diagnosis), during treatment (weeks 1, 2 and 4) and 2 weeks after treatment completion (week 26). These samples were divided into successful (cured) and unsuccessful (failed) treatment outcome groups and analyzed using a GCxGC-TOFMS metabolomics research approach. Results The metabolite data collected showed clear differentiation of the cured and failed treatment outcome groups using the samples collected at the time of diagnosis, i.e. before any treatment was administered. Conclusions The treatment failure group was characterized by an imbalanced gut microbiome, in addition to elevated levels of metabolites associated with abnormalities in the long-chain fatty acid β-oxidation pathway, accompanied by reduced l-carnitine and short-chain fatty acids, indicative of a mitochondrial trifunctional protein defect in particular. Furthermore, an altered amino acid metabolism was also observed in these patients, which confirms previous findings and associations to increased interferon gamma due to the host’s immune response to M. tuberculosis and a compromised insulin secretionen_US
dc.language.isoenen_US
dc.publisherSpringeren_US
dc.subjectBiomarkersen_US
dc.subjectM. tuberculosisen_US
dc.subjectMetabolomicsen_US
dc.subjectTreatment failureen_US
dc.subjectTuberculosisen_US
dc.subjectUrineen_US
dc.titleUrinary metabolite markers characterizing tuberculosis treatment failureen_US
dc.typeArticleen_US
dc.contributor.researchID21637156 - Luies, Laneke
dc.contributor.researchID10061533 - Mienie, Lodewyk Jacobus
dc.contributor.researchID10799508 - Loots, Du Toit


Files in this item

FilesSizeFormatView

There are no files associated with this item.

This item appears in the following Collection(s)

Show simple item record